Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology

Tremorine-induced tremors model is used to evaluate antiparkinsonian drugs because rest tremor is a sign that distinguishes Parkinson's disease (PD) from other diseases. The effects of crude ethanolic extract (CEE) and total acetate fraction (TAF) of Plumbago scandens were investigated at several doses. These extracts at doses of 125 and 250 mg/kg i.p. failed to reduce tremors in tremorine-treated mice. TAF showed significant effects only at a dose of 500 mg/kg. Both CEE and TAF at doses of 1000 and 2000 mg/kg i.p. suppressed the tremors in a dose-dependent fashion for 60 min. Biperiden, an anticholinergic drug, was used as standard at a dose of 3 mg/kg i.p. This study suggests that P. scandens is a plant with possible therapeutic value for PD.

[1]  A. Cáceres,et al.  Neuropharmacological profile of ethnomedicinal plants of Guatemala. , 2001, Journal of ethnopharmacology.

[2]  P. Riederer,et al.  Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man , 2005, Journal of Neural Transmission.

[3]  R. Young Update on Parkinson's disease. , 1999, American family physician.

[4]  M. Fonteles,et al.  Screening for anticancer activity of plants from the Northeast of Brazil , 1997 .

[5]  B. Manyam,et al.  Mucuna pruriens proves more effective than L‐DOPA in Parkinson's disease animal model , 1997 .

[6]  R. Elble Central mechanisms of tremor. , 1996, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[7]  I. Raskin,et al.  Plants and human health in the twenty-first century. , 2002, Trends in biotechnology.

[8]  K. Fukuzaki,et al.  Effects of Ropinirole on Various Parkinsonian Models in Mice, Rats, and Cynomolgus Monkeys , 2000, Pharmacology Biochemistry and Behavior.

[9]  R. Pérez,et al.  Neuropharmacological activity of Solanum nigrum fruit. , 1998, Journal of ethnopharmacology.

[10]  Coward Dm,et al.  The pharmacology of N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride (LON-954) a new tremorogenic agent. , 1977 .

[11]  W. Cui,et al.  Pharmacology: Anti‐nicotinic Properties of Anticholinergic Antiparkinson Drugs , 1998 .

[12]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[13]  R. Llinás,et al.  Properties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurones in vitro. , 1981, The Journal of physiology.

[14]  Guanghui Wang,et al.  Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine , 2001, Psychopharmacology.

[15]  P. Slater,et al.  Effects of naltrexone and prolyl-leucyl-glycinamide on drug-induced tremor and rigidity in the rat , 1981, Neuropharmacology.

[16]  T. Klockgether,et al.  Effects of the antiparkinsonian drug budipine on central neurotransmitter systems. , 1996, European journal of pharmacology.

[17]  S. M. Rates,et al.  Plants as source of drugs. , 2001, Toxicon : official journal of the International Society on Toxinology.

[18]  P. Slater,et al.  Effect of lesioning dopamine, noradrenaline and 5-hydroxytryptamine pathways on tremorine-induced tremor and rigidity , 1982, Neuropharmacology.

[19]  H. Shinozaki,et al.  Modification of drug-induced tremor by systemic administration of kainic acid and quisqualic acid in mice , 1987, Neuropharmacology.

[20]  R. Bye,et al.  Antimicrobial and cytotoxic activities of some crude drug extracts from Mexican medicinal plants. , 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[21]  P. K. Mohan,et al.  Association of l-DOPA with recovery following Ayurveda medication in Parkinson’s disease , 2000, Journal of the Neurological Sciences.

[22]  R. Llinás,et al.  Oscillatory properties of guinea‐pig inferior olivary neurones and their pharmacological modulation: an in vitro study. , 1986, The Journal of physiology.

[23]  J. Harindran.,et al.  Pimprinine, an extracellular alkaloid produced by Streptomyces CDRIL-312: fermentation, isolation and pharmacological activity. , 2001, Journal of biotechnology.

[24]  V. Sethy,et al.  Pharmacokinetics of muscarinic cholinergic drugs as determined by ex vivo (3H)-oxotremorine-M binding. , 1990, Journal of pharmacological methods.

[25]  J. Salamone,et al.  Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. , 1997, European journal of pharmacology.

[26]  M. Palkovits,et al.  Regional distribution of muscarinic cholinergic receptors in rat brain , 1978, Brain Research.

[27]  J. Bhattacharyya,et al.  Epi-isoshinanolone from Plumbago scandens , 1986 .

[28]  J. Harborne Comparative biochemistry of the flavonoids-IV. Correlations between chemistry, pollen morphology and systematics in the family Plumbaginaceae. , 1967 .

[29]  D. Brocks Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective. , 1999, Journal of Pharmacy & Pharmaceutical Sciences.

[30]  P. Slater,et al.  Effects of lesioning basal ganglia nuclei and output pathways on tremorine-induced tremor in rats , 1982, Journal of the Neurological Sciences.

[31]  J. Carr Tremor in Parkinson's disease. , 2002, Parkinsonism & related disorders.